As shown in Figure 3A, MAIT cells from COVID-19 patients expressed significantly higher levels of the activation markers CD38, CD69 and HLA-DR, as well as of the exhaustion markers CTLA-4 and PD-1, compared to healthy controls. This evidence concerns the gene CD69 and COVID-19.